The UK's developing landscape of mind-altering substances is seeing a noticeable shift, moving far outside the traditional concentration on magic mushrooms and LSD . Attention is increasingly centered on newer compounds, like dimethyltryptamine, CBG a phytocannabinoid showing encouraging medicinal properties, and an assortment of additional substan